Profile

• 2004 – 2010: Degree in Medicine, National and Kapodistrian University of Athens
• 2012 – 2016: Core Medical Training, Mersey Deanery and The Royal Liverpool University Hospitals UK 
• 2016: Membership of The Royal College of Physicians UK (MRCP)
• 2016 – 2020: Specialty Training in Medical Oncology, The Clatterbridge Cancer Centre (Liverpool and Wirral) UK
• 2020: Specialty Certification for Medical Oncology, UK
• Special Interest in Breast Medical Oncology as Consultant Medical Oncologist, The Christie NHS Foundation Trust, UK
• 2018 – 2020: MSc in Oncogenomics, University of Manchester UK
• 2019 – 2020: MDSC160 in Palliative Care, University of Liverpool UK
• 2020: HMX (Harvard, US) Advanced Immuno-oncology and precision Oncology Course. Certification of Achievement
• 2020: The Clinical Leadership course Keele University UK
• 2022: Teaching the Clinical Teachers Course, The Oxford University UK
• Clinical Lecturer University of Bangor, UK

2020: Mechanisms of primary resistance in CDK4/6 inhibition in patients with hormone receptor positive, HER2-receptor negative metastatic breast cancer

 

• 2012 – 2016: Core Medical Training, Mersey Deanery and The Royal Liverpool University Hospitals, UK
• 2016 - 2020: Specialist Registrar (National Training Programme), The Clatterbridge Cancer Centre, Liverpool UK
• 2020: Consultant Medical Oncologist, The Clatterbridge Cancer Centre, Liverpool UK
• 2020 – 2023: Consultant Medical Oncologist in Breast Oncology, The Christie NHS Foundation Trust, Manchester, UK
• 2023 – 2024: Consultant Medical Oncologist, North Wales Health Board UK
• 2023 – 2024: Clinical Lecturer University of Bangor, UK

• Diagnosis and Treatment of solid tumours
• Special Interest in Breast and Colorectal Ca 
• Supportive and Palliative Care

 

2019: Quality Improvement Award in Clatterbridge Cancer Centre, Project of the Year 2019 Best Quality Improvement Project in The Clatterbridge Cancer Centre for 2019 for the Project: ‘Use of Taxanes in adjuvant/neo-adjuvant setting in early breast cancer’

 

• RCP: The Royal College of Physicians (UK)
• ACP: Association of Cancer Physicians (UK)
• ESMO: European Society of Medical Oncology

 

Participation as sub-investigator and co-investigation in numerous Phase I -III clinical trials in The Clatterbridge Cancer Centre (Liverpool, UK) and The Christie NHS Foundation Trust (Manchester, UK)